Funding for this research was provided by:
Chief Scientist Office (TCS/18/43)
Received: 27 April 2020
Accepted: 30 November 2020
First Online: 7 January 2021
Ethics approval and consent to participate
: Ethical approval has been obtained from the East of Scotland Research Ethics Committee (NHREC 19/ES/0079). All participants will be required to give informed written consented to take part in the study.
: Not applicable
: Andrew Horne receives grant funding from the NIHR, MRC, Chief Scientist’s Office, Wellcome Trust, Wellbeing of Women, Ferring and Roche. He has received honoraria for consultancy for Ferring, Roche Diagnostics, Nordic Pharma and Abbvie. Lone Hummelshoj has received honoraria for advice to AbbVie. The remaining authors declare that they have no competing interests.